ImmunityBio
IBRX
IBRX
141 hedge funds and large institutions have $209M invested in ImmunityBio in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $311M → $209M (-$102M)
60% less call options, than puts
Call options by funds: $2.96M | Put options by funds: $7.39M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
141
Holding in Top 10
–
Calls
$2.96M
Puts
$7.39M
Top Buyers
| 1 | +$5.46M | |
| 2 | +$2.28M | |
| 3 | +$1.48M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.46M |
| 5 |
Millennium Management
New York
|
+$1.29M |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$1.28M | |
| 3 | -$1.01M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$974K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$818K |